About the Targeted Oncology Session
Targeted oncology, a promising field within cancer research, focuses on treatments tailored to individual patients based on their genetic makeup, tumor characteristics, and other factors. This personalized approach offers the potential for more effective and less toxic therapies compared to traditional treatments. Targeted therapies often involve drugs that specifically target molecules involved in cancer growth and progression, such as certain proteins or genetic mutations. Advancements in genomics and molecular biology have facilitated the development of these therapies, allowing oncologists to better match treatments to the unique molecular profiles of patients' tumors. As research in targeted oncology continues to evolve, it holds great promise for improving outcomes and quality of life for cancer patients.
Topics Covered in Targeted Oncology
Oncogenic Drivers
Synthetic Lethality
Protein Degraders
Resistance Monitoring
Genomic Biomarkers
Tumor Heterogeneity
Related Scientific Sessions at CIOC 2027
Why Attend the Targeted Oncology Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Targeted Oncology work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Targeted Oncology research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Targeted Oncology track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Targeted Oncology Conference 2027 — FAQs
What is the Targeted Oncology track at CIOC 2027?
The Targeted Oncology track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Targeted Oncology. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Targeted Oncology sessions?
Cancer researchers and clinicians, educators and students with an interest in Targeted Oncology are all welcome — whether presenting or attending.
Can I present my research in the Targeted Oncology track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Targeted Oncology sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Targeted Oncology track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.